At current rates of progress, the target under the Sustainable Development Goals to end the tuberculosis (TB) epidemic by 2030 will not be achieved because of the impact of COVID-19 on TB programmes. According to an estimate by Imperial College London, the impact of COVID-19 could reverse progress made on tackling TB back to 2013 levels. In addition, TB Research and Development (R&D) has been impacted with delays in clinical trials due to lockdowns or shifted focus onto COVID-19. It should be noted that COVID-19 has utilised assets invested in TB and HIV research and development. Prior to COVID-19, it was predicted that without new tools to tackle TB, the SDG target would not be achieved for another 100 years at least and progress against the disease was already being threatened by drug-resistance (DR-TB). The situation is therefore critical and it is vital that civil society understands the situation. TBEC is therefore running a series of webinars exploring how COVID-19 will impact on TB R&D. To join these, please see the information below. 

As the world comes together to tackle the novel coronavirus (COVID-19) pandemic, it is important to ensure that TB prevention and care approaches are adapting appropriately to offer uninterrupted, safe, and high-quality TB services. Considering the similarity of TB and COVID-19 illnesses in disease presentation and transmission, as well as synergies in the response (e.g. prevention, infection control, adherence support, etc), the pandemic presents many questions for the TB field that requires learning through research and innovation. 

Join TB Europe Coalition as we launch a series of webinars on research and development and will welcome speakers from TAG, IAVI, MSF, FIND and TB Alliance. The series will be broken out in three different webinars. The first will focus on vaccines, the second on diagnostic tools and policy, and the third will focus on treatment for drug-resistant TB.

For more information click here.

Please find the registration links below. The webinar will take place in Russian and English, with consecutive translation 

Webinar 1: The Impact of COVID-19 on TB Research and Development on Vaccines

Time: Monday, 28th September 2020, 3 pm CET

Registration: https://us02web.zoom.us/webinar/register/WN_AF73X14cS4aZUOHx3cP0FQ 

Webinar 2: he Impact of COVID-19 on Research and Development on TB Diagnostic Tools and the Lessons Learnt about R&D Policy Reform

Time: Friday, 2nd October 2020, 3 pm CET 

Registration: https://us02web.zoom.us/webinar/register/WN_Hao6LQEdQ2mRTp4P5ToxFQ 

Webinar 3: The Impact of COVID-19 on Research and Development on TB Drug Development 

Time: Wednesday, 7th October 2020, 3 pm CET

Registration: https://us02web.zoom.us/webinar/register/WN_DwpCZl2DT0Wh42YLggR0cw 

The registration form may be in English – if you are having any problems, please contact coordinator@tbcoalition.eu.